ReNeuron Stem Cell Stroke Therapy Successfully Completes Pre-Clinical Trials
LONDON (Thomson Financial) - ReNeuron Group PLC said it has successfully completed pre-clinical trials for its ReN001 stem cell therapy product for the treatment of strokes.